WASHINGTON — Viltolarsen (Viltepso) injection has been licensed to address Duchenne muscular dystrophy (DMD) in patients with a confirmed mutation in the DMD gene amenable…
WASHINGTON — Viltolarsen (Viltepso) injection has been licensed to address Duchenne muscular dystrophy (DMD) in patients with a confirmed mutation in the DMD gene amenable…